Cardiology Research Review: Issue 154, with commentary by A/Prof John Amerena

In this issue:

• The artificial sweetener erythritol and atherothrombotic disease risk
• Acute health effects of coffee consumption
• Does KDC score predict CV death and non-fatal CV events?
• Heterogeneity in BP response to different antihypertensive drug classes
• Patients’ and their physicians’ perspectives on oral anticoagulants for AF
• Long-term outcomes according to LDL level achieved with evolocumab
• Prevalence and prognostic significance of bradyarrhythmias in patients screened for AF
• Effects of dapagliflozin according to duration of HF
• Effects of SGLT2 inhibition on the risk of anthracycline-associated cardiotoxicity
• The role of beta-blockers beyond one year post MI

Download Cardiology_Research_Review_Issue_154. with commentary by A/Prof John Amerena.